- Home
- GOSS vs ARQ Comparison
GOSS vs ARQ Comparison
Compare GOSS & ARQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GOSS
- ARQ
- Stock Information
- Founded
- GOSS 2015
- ARQ 1996
- Country
- GOSS United States
- ARQ United States
- Employees
- GOSS N/A
- ARQ N/A
- Industry
- GOSS Biotechnology: Pharmaceutical Preparations
- ARQ
- Sector
- GOSS Health Care
- ARQ
- Exchange
- GOSS Nasdaq
- ARQ NYSE
- Market Cap
- GOSS 230.8M
- ARQ 249.0M
- IPO Year
- GOSS 2019
- ARQ N/A
- Fundamental
- Price
- GOSS $0.97
- ARQ $5.41
- Analyst Decision
- GOSS Strong Buy
- ARQ
- Analyst Count
- GOSS 5
- ARQ 0
- Target Price
- GOSS $9.20
- ARQ N/A
- AVG Volume (30 Days)
- GOSS 942.3K
- ARQ 378.8K
- Earning Date
- GOSS 11-07-2024
- ARQ 08-12-2024
- Dividend Yield
- GOSS N/A
- ARQ N/A
- EPS Growth
- GOSS N/A
- ARQ N/A
- EPS
- GOSS N/A
- ARQ N/A
- Revenue
- GOSS $95,842,000.00
- ARQ $105,078,000.00
- Revenue This Year
- GOSS N/A
- ARQ $4.58
- Revenue Next Year
- GOSS N/A
- ARQ $40.31
- P/E Ratio
- GOSS N/A
- ARQ N/A
- Revenue Growth
- GOSS N/A
- ARQ 12.87
- 52 Week Low
- GOSS $0.45
- ARQ $1.60
- 52 Week High
- GOSS $1.60
- ARQ $8.26
- Technical
- Relative Strength Index (RSI)
- GOSS 48.28
- ARQ 44.03
- Support Level
- GOSS $0.98
- ARQ $5.12
- Resistance Level
- GOSS $1.09
- ARQ $5.78
- Average True Range (ATR)
- GOSS 0.06
- ARQ 0.32
- MACD
- GOSS -0.01
- ARQ -0.02
- Stochastic Oscillator
- GOSS 21.83
- ARQ 26.32
About GOSS Gossamer Bio Inc.
Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.
About ARQ ARQ INC
Arq Inc is an environmental technology company principally engaged in the sale of consumable air, water, and soil treatment solutions including activated carbon (AC) and chemical technologies. The company manufactures and sells activated carbon and other chemicals used to capture and remove contaminants for the coal-fired power generation, industrial, municipal water and air, water and soil treatment and remediation markets. Some of the products in its portfolio are Powdered Activated Carbon, Granular Activated Carbon, and Colloidal Carbon Product among others.